Significant Pharmaceuticals Reported In Us Patents  at Meripustak

Significant Pharmaceuticals Reported In Us Patents

Books from same Author: Thomas F DeRosa

Books from same Publisher: ELSEVIER

Related Category: Author List / Publisher List


  • Price: ₹ 17640.00/- [ 27.00% off ]

    Seller Price: ₹ 12877.00

Sold By: Store4Doctors      Click for Bulk Order

Offer 1: Get 27.00 % + Flat ₹ 75 discount on shopping of ₹ 500 [Use Code: MPSTK75]

Offer 2: Get 27.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 27.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Thomas F DeRosa
    PublisherELSEVIER
    ISBN9780080453446
    Pages700
    BindingHardbound
    LanguageEnglish
    Publish YearJune 2007

    Description

    ELSEVIER Significant Pharmaceuticals Reported In Us Patents by Thomas F DeRosa

    Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference an.